Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review
about
Effects of Pharmacotherapy on Combat-Related PTSD, Anxiety, and Depression: A Systematic Review and Meta-Regression AnalysisPharmacological treatment of PTSD - established and new approachesPatient-reported outcomes in post-traumatic stress disorder. Part II: focus on pharmacological treatmentReal-Time fMRI Neurofeedback with War Veterans with Chronic PTSD: A Feasibility StudyPTSD: from neurobiology to pharmacological treatmentsRecent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.Preclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorderBiomarkers in posttraumatic stress disorder: overview and implications for future researchTherapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder.Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats--a possible mechanism for the persistence of traumatic memories in PTSDPosttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospitalEmotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change.Eye movement desensitization and reprocessing for posttraumatic stress disorder in bipolar disorder.Best practice guide for the treatment of nightmare disorder in adults.Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder.Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.Moderate treadmill exercise rescues anxiety and depression-like behavior as well as memory impairment in a rat model of posttraumatic stress disorderGrape powder prevents cognitive, behavioral, and biochemical impairments in a rat model of posttraumatic stress disorderA diet enriched with curcumin impairs newly acquired and reactivated fear memoriesPredictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder.A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.Pharmacotherapy for Post-traumatic Stress Disorder In Combat Veterans: Focus on Antidepressants and Atypical Antipsychotic AgentsNoradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependenceThe influence of emergency contraception on post-traumatic stress symptoms following sexual assault.Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trialTreatment of nightmares with prazosin: a systematic review.Anxiolytic effects of flavonoids in animal models of posttraumatic stress disorder.Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortexPTSD Treatment for Veterans: What's Working, What's New, and What's Next.Posttraumatic stress disorder and stress-related disorders.Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.Sleep in psychiatric disorders: where are we now?Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review.Anticonvulsants to treat post-traumatic stress disorder.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder.Pharmacology for sleep disturbance in PTSD.
P2860
Q22255524-19632942-AEE4-425B-8AD4-1F17F412B71CQ24633256-D90C2F4D-BD67-4CD9-B0F6-916C8D76A4C0Q26829332-0C931073-B517-4886-B378-583DA90E38E1Q27303728-30578674-E880-4D30-B9B8-03CA79C0ACF9Q28070159-9F000211-F1D0-4EBC-8681-18E214898C97Q30442231-11734566-57DE-452B-AB7A-C7199A11B6D2Q30446686-1246D215-AA3C-4036-AC55-9B8B5C1E9878Q30448609-6B042A83-0969-4E2B-B1EF-989A64FF6941Q30452378-BEC29306-FE26-4FA5-A0F7-91B61E548898Q30457584-72E94526-5ACC-4337-AC92-3A2D03A50C48Q30463954-FCF98E2A-AFB0-4E51-87A3-6451898FDBA0Q30830272-CDC86D29-5BCA-4EB4-9F5F-743E4602536FQ34012287-820F7CAC-1CA3-4CB6-87CB-3E16FDE43FD8Q34058202-02C4A293-D317-4E78-B402-3B7738CDABD9Q34122994-7490422D-A677-4969-8AFE-91B2B47EF584Q34126472-28173741-7C92-42DF-B942-D4F817DF3356Q34206188-5A4BACE1-BFEE-4BF1-877F-874690474381Q34482680-ADA3B7BB-3BF5-41A8-9787-CE9BD31007A9Q35053258-E71FD7AA-BED2-4C3D-BB86-658799627908Q35085737-1521677C-03F2-45F5-A176-0EB5A06E2D66Q35200059-16FA679D-5807-4C6F-881E-4812DB65D06BQ35223508-C60301B7-36A4-45E5-B542-3F492DE6E18EQ35492036-16F6BD70-46BB-40EB-A6A3-95678A9AC009Q35630395-7ADB84D2-C6A4-4EE3-A423-356FB2208713Q35752941-9E481FDB-0B1D-41FD-893C-F6C92FBF738AQ35760199-58ADD47A-EEE0-4DCC-A426-56861526067EQ36199590-771E6055-E267-4794-B6E0-511FF633FC5BQ36283417-4FC8C862-98BC-4514-869C-D8EB23EDD426Q36513104-10ABF800-DF66-440E-98AE-C35EE92E5DD0Q36517049-6A8FAF60-9E04-4A79-8CCC-7E1A59B2EB19Q36742509-A1203EDB-C786-4EFD-93FC-A24B78872BAFQ37304525-D52AF016-6603-4024-A1DB-2F4E4526CB37Q37353639-11DCC955-C933-42FF-8056-A629DA62A7EEQ37499811-BFBE4296-0D44-4036-A5C8-3D0A18ED769BQ37779583-CA42ED43-8486-4257-9318-AF7293B84286Q38156414-119F0C3A-FB87-4597-AAE0-F814F58181A1Q38240674-1BDCC049-5EEC-4E92-9029-14CDAC279EBCQ38255794-BA48C8D5-986B-4A53-8961-8167823BB0F1Q38719540-D46C809C-77EF-4D62-BB1E-34EDA516EE42Q38726468-65E3F86F-9E11-4913-80A2-A934FA691DAA
P2860
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacologic alternatives to ...... disorder: a systematic review
@ast
Pharmacologic alternatives to ...... disorder: a systematic review
@en
Pharmacologic alternatives to ...... disorder: a systematic review
@nl
type
label
Pharmacologic alternatives to ...... disorder: a systematic review
@ast
Pharmacologic alternatives to ...... disorder: a systematic review
@en
Pharmacologic alternatives to ...... disorder: a systematic review
@nl
prefLabel
Pharmacologic alternatives to ...... disorder: a systematic review
@ast
Pharmacologic alternatives to ...... disorder: a systematic review
@en
Pharmacologic alternatives to ...... disorder: a systematic review
@nl
P2093
P2860
P3181
P1476
Pharmacologic alternatives to ...... disorder: a systematic review
@en
P2093
Carla Marques-Portella
Charles R Marmar
Gustavo Kinrys
Ivan Figueira
Mauro V Mendlowicz
William Berger
P2860
P304
P3181
P356
10.1016/J.PNPBP.2008.12.004
P407
P577
2009-03-17T00:00:00Z